24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publication dates

All regions

Insulin Industry, November 2014 Market Reports from Top Publishers

You might be interested in: Medical Equipment, Drug, Therapeutics, more »


 
1-20 of about 300 reports for Insulin

InsuLine Medical Ltd. - Strategic SWOT Analysis Review

InsuLine Medical Ltd. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Of insulin treatments. Its products include insupad and insupatch. insuline medical's insupad is a patch for syringes and insulin pens. The company's insupatch is used as a catheter and pump holder for pumps ...

Physician Views: Will next-generation long-acting insulins prove compelling?

Physician Views: Will next-generation long-acting insulins prove compelling?

  • $ 681
  • Industry report
  • November 2014
  • by Firstword Pharma

... Lantus (Us respondents assume that biosimilar lantus is not rated as interchangeable) physician views: will next-generation long-acting insulins prove compelling ...

Physician Views: What opportunity for biosimilar basal insulin?

Physician Views: What opportunity for biosimilar basal insulin?

  • $ 681
  • Industry report
  • November 2014
  • by Firstword Pharma

... Formulary positioning.Suggestions that aggressive price increases for lantus have caught up with sanofi in the us payer environment come as the basal insulin market is nearing an important juncture ...

Global Insulin Delivery Devices Market Outlook 2018

Global Insulin Delivery Devices Market Outlook 2018

  • $ 1 600
  • Industry report
  • November 2014
  • by RNCOS

... Preferences.' Study thus leads to the proposition that innovation has huge scope in the field of insulin delivery and its analysts have elaborate information on some of the emerging insulin ...

2014 Market Research Report on Global Insulin Industry

2014 Market Research Report on Global Insulin Industry

  • $ 2 200
  • Industry report
  • November 2014
  • by QY Research Group

... And news analysis, etc. For international and china market analysis, the report analyzes insulin markets in china and other countries or regions (such as us, europe, japan, etc) by presenting ...

Hanmi Pharmaceuticals, Co. Ltd. - Product Pipeline Review - 2014

Hanmi Pharmaceuticals, Co. Ltd. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • October 2014
  • by Global Markets Direct

... R&d progress 52insulin human long acting 53product description 53mechanism of action 53r&d progress 53(rosuvastatin calcium + fenofibric acid) 54product description 54 ...

Pen Needles Market by Type (Standard and Safety), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, and 12mm), Therapy (Insulin, Glucagon-like peptide, Growth Hormones) - Analysis & Global Forecast to 2019

Pen Needles Market by Type (Standard and Safety), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, and 12mm), Therapy (Insulin, Glucagon-like peptide, Growth Hormones) - Analysis & Global Forecast to 2019

  • $ 4 650
  • Industry report
  • October 2014
  • by MarketsandMarkets

... For the largest share of the global pen needles market, by type, while 6mm pen needles accounted for the largest share of the pen needles market, by needle length. insulin therapy account for major share of the pen ...

Insuline Medical Ltd

Insuline Medical Ltd

  • $ 55
  • Company report
  • October 2014
  • by Wright Investors' Service

... insuline medical ltd a textual analysis of the financial results for insuline medical ltd compared to selected competitors. Also included are quantitative analyses of the company's financial ...

Insulin Market in China 2014-2018

Insulin Market in China 2014-2018

  • $ 2 500
  • Industry report
  • October 2014
  • by Infiniti Research Limited

... They last. In diabetic condition, the pancreas no longer produces adequate insulin or the cells stop responding to the insulin that is produced, leading to rise in blood glucose level.Technavio's analysts ...

Cardiometabolic Drug News OCTOBER 2014

Cardiometabolic Drug News OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

... Of collategene in critical limb ischaemiaindustry brief - byetta meets primary endpoint in trial versus bolus insulin cardiometabolic drug news october 2014 ...

About 2 400 reports for Insulin

Download Unlimited Documents from Trusted Public Sources

Novo Nordisk Annual Report 2013

  • Business Strategy
  • January 2013
    116 pages
  • Diabete  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.